Growth Metrics

Integra Lifesciences Holdings (IART) Income from Continuing Operations (2009 - 2026)

Integra Lifesciences Holdings recorded quarterly Income from Continuing Operations of 4617000.0 in Q1 2026, down 170.95% quarter-over-quarter from 1704000.0 in Q4 2025, and up 81.75% year-over-year from 2540359.39 in Q1 2025.

Integra Lifesciences Holdings' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 4617000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 81.75% year-over-year to 4617000.0; the TTM figure through Mar 2026 stood at 495798000.0 (down 1612.31% YoY), while the FY2025 annual figure was 516474000.0, down 7337.7% from the prior year.
  • Income from Continuing Operations came in at 4617000.0 for Q1 2026 at Integra Lifesciences Holdings, down from 1704000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 52946000.0 in Q4 2022 to a low of 484073000.0 in Q2 2025.
  • A 5-year average of 16455470.59 and a median of 4184000.0 in 2023 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations sank 3803.18% in 2025 and surged 81.75% in 2026, its largest moves.
  • Integra Lifesciences Holdings' Income from Continuing Operations stood at 52946000.0 in 2022, then tumbled by 62.54% to 19834000.0 in 2023, then slipped by 2.01% to 19435000.0 in 2024, then plunged by 108.77% to 1704000.0 in 2025, then plunged by 170.95% to 4617000.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered 4617000.0, 1704000.0, and 5404000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn -4.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4.62 Mn
Dec 31, 2025 -1.70 Mn
Sep 30, 2025 -5.40 Mn
Jun 30, 2025 -484.07 Mn
Mar 31, 2025 -25.29 Mn
Dec 31, 2024 19.44 Mn
Sep 30, 2024 -10.70 Mn
Jun 30, 2024 -12.40 Mn
Mar 31, 2024 -3.28 Mn
Dec 31, 2023 19.83 Mn
Sep 30, 2023 19.50 Mn
Jun 30, 2023 4.18 Mn
Mar 31, 2023 24.23 Mn
Dec 31, 2022 52.95 Mn
Sep 30, 2022 49.92 Mn
Jun 30, 2022 44.79 Mn
Mar 31, 2022 32.90 Mn
Dec 31, 2021 45.38 Mn
Sep 30, 2021 43.23 Mn
Jun 30, 2021 35.07 Mn
Mar 31, 2021 45.39 Mn
Dec 31, 2020 92.74 Mn
Sep 30, 2020 32.34 Mn
Jun 30, 2020 -369,000.00
Mar 31, 2020 9.18 Mn
Dec 31, 2019 15.32 Mn
Sep 30, 2019 -27.61 Mn
Jun 30, 2019 29.74 Mn
Mar 31, 2019 32.76 Mn
Dec 31, 2018 25.14 Mn
Sep 30, 2018 13.30 Mn
Jun 30, 2018 11.38 Mn
Mar 31, 2018 10.99 Mn
Dec 31, 2017 44.36 Mn
Sep 30, 2017 3.16 Mn
Jun 30, 2017 10.84 Mn
Mar 31, 2017 6.39 Mn
Dec 31, 2016 28.25 Mn
Sep 30, 2016 20.14 Mn
Jun 30, 2016 12.76 Mn
Mar 31, 2016 13.42 Mn
Dec 31, 2015 14.98 Mn
Sep 30, 2015 -31.88 Mn
Jun 30, 2015 12.02 Mn
Mar 31, 2015 11.73 Mn
Dec 31, 2014 20.41 Mn
Sep 30, 2014 8.99 Mn
Jun 30, 2014 4.83 Mn
Mar 31, 2014 2.21 Mn
Dec 31, 2013 63.70 Mn
Sep 30, 2013 -30.33 Mn
Jun 30, 2013 1.52 Mn
Mar 31, 2013 -6.03 Mn
Dec 31, 2012 12.79 Mn
Sep 30, 2012 13.21 Mn
Jun 30, 2012 8.51 Mn
Mar 31, 2012 6.69 Mn
Dec 31, 2011 4.56 Mn
Sep 30, 2011 11.24 Mn
Jun 30, 2011 699,000.00
Mar 31, 2011 11.49 Mn
Dec 31, 2010 18.81 Mn
Sep 30, 2010 16.48 Mn
Jun 30, 2010 15.16 Mn
Mar 31, 2010 15.22 Mn
Dec 31, 2009 -24.77 Mn
Sep 30, 2009 14.43 Mn
Jun 30, 2009 11.23 Mn